BioCentury | Nov 15, 2019
Product Development

Minerva on the verge in neuropsychiatry with two compounds close to verdict

...ADRA1a - Adrenergic receptor alpha 1a ADRA1b - Adrenergic receptor alpha 1b DAAO (DAO) - D-amino-acid oxidase...
BioCentury | May 30, 2016

Taking Takeda global

...database contains no other disclosed programs that target CH24H. TAK-831 is an oral inhibitor of D-amino-acid oxidase...
BioCentury | Dec 10, 2012
Company News

Cerecor, Johns Hopkins University deal

...granted Cerecor an option to license exclusive, worldwide rights to develop and commercialize small molecule D-amino-acid oxidase...
BioCentury | Apr 15, 2010
Distillery Therapeutics

Indication: Neurology

...Indication Target/marker/ pathway Summary Licensing status Publication and contact information Neurology Amyotrophic lateral sclerosis (ALS) d-Amino-acid oxidase...
BioCentury | Jun 4, 2009
Distillery Therapeutics

Indication: Neurology

...This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Schizophrenia d-Amino-acid oxidase...
BioCentury | Sep 30, 2002
Company News

Genset other research news

Analysis of SNPs published in the Proceedings of the National Academy of Sciences identified genes associated with schizophrenia. One particular gene, G72, was found to interact with D-amino acid oxidase ( DAAO ), an enzyme involved...
Items per page:
1 - 6 of 6